What is the success rate of tremfya for moderate to severe psoriasis?

How does Tremfya compare to other psoriasis treatments?

Tremfya works by targeting interleukin-23 to reduce inflammation in the skin. [1] It shows higher skin clearance rates than older biologics such as adalimumab. [2]

When does Tremfya patent expire?

Tremfya's primary patent expires in 2031. [3]

What clinical data supports its success rate?

Clinical trials report PASI 90 scores of 70-75% at week 16 for patients with moderate to severe plaque psoriasis. [4]

What side effects are patients asking about?

Common complaints include upper respiratory infections and injection-site reactions. [5]

How long does esketamine nasal spray keep people on?

Esketamine nasal spray is a different treatment for depression and not related to psoriasis.